Endorectal MRI of prostate cancer: Incremental prognostic importance of gross locally advanced disease

Valdair F. Muglia, Antonio C. Westphalen, Zhen J. Wang, John Kurhanewicz, Peter R. Carroll, Fergus Coakley

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

OBJECTIVE. The purpose of this study was to determine the frequency and incremental prognostic importance of gross locally advanced disease seen at endorectal MRI in patients with prostate cancer. MATERIALS AND METHODS. We retrospectively identified the cases of all patients with biopsy-proven prostate cancer who underwent pretreatment endorectal MRI over a 6-year period (n = 1777). Three experienced radiologists identified by consensus patients with gross locally advanced disease, defined as unequivocal extracapsular extension or unequivocal seminal vesicle invasion. Outcome among these patients was compared with that in a control group without gross locally advanced disease matched by D'Amico risk stratification. RESULTS. Sixty-six of 1777 (3.7%) patients had gross locally advanced disease. One of 1085 (0.1%) patients had low-risk disease, 25 of 489 (5.1%) had intermediate-risk disease, and 40 of 203 (19.7%) had high-risk disease. Follow-up data were available for 44 of these 66 patients. During a median follow-up period of 79 months, biochemical failure and metastasis had developed in 17 and 6 of these 44 patients compared with 9 and none of the 65 patients in the control group (p <0.001). CONCLUSION. Almost 4% of patients with prostate cancer, particularly those with intermediate- and high-risk disease, have gross locally advanced disease at endorectal MRI and have a significantly worse prognosis than matched controls. These patients may be candidates for more aggressive treatment.

Original languageEnglish (US)
Pages (from-to)1369-1374
Number of pages6
JournalAmerican Journal of Roentgenology
Volume197
Issue number6
DOIs
StatePublished - Dec 2011
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Control Groups
Seminal Vesicles
Neoplasm Metastasis
Biopsy

Keywords

  • MR spectroscopy
  • MRI
  • Prostate cancer

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Endorectal MRI of prostate cancer : Incremental prognostic importance of gross locally advanced disease. / Muglia, Valdair F.; Westphalen, Antonio C.; Wang, Zhen J.; Kurhanewicz, John; Carroll, Peter R.; Coakley, Fergus.

In: American Journal of Roentgenology, Vol. 197, No. 6, 12.2011, p. 1369-1374.

Research output: Contribution to journalArticle

Muglia, Valdair F. ; Westphalen, Antonio C. ; Wang, Zhen J. ; Kurhanewicz, John ; Carroll, Peter R. ; Coakley, Fergus. / Endorectal MRI of prostate cancer : Incremental prognostic importance of gross locally advanced disease. In: American Journal of Roentgenology. 2011 ; Vol. 197, No. 6. pp. 1369-1374.
@article{9545fcafe03a49cdbe4e5c932f327e8b,
title = "Endorectal MRI of prostate cancer: Incremental prognostic importance of gross locally advanced disease",
abstract = "OBJECTIVE. The purpose of this study was to determine the frequency and incremental prognostic importance of gross locally advanced disease seen at endorectal MRI in patients with prostate cancer. MATERIALS AND METHODS. We retrospectively identified the cases of all patients with biopsy-proven prostate cancer who underwent pretreatment endorectal MRI over a 6-year period (n = 1777). Three experienced radiologists identified by consensus patients with gross locally advanced disease, defined as unequivocal extracapsular extension or unequivocal seminal vesicle invasion. Outcome among these patients was compared with that in a control group without gross locally advanced disease matched by D'Amico risk stratification. RESULTS. Sixty-six of 1777 (3.7{\%}) patients had gross locally advanced disease. One of 1085 (0.1{\%}) patients had low-risk disease, 25 of 489 (5.1{\%}) had intermediate-risk disease, and 40 of 203 (19.7{\%}) had high-risk disease. Follow-up data were available for 44 of these 66 patients. During a median follow-up period of 79 months, biochemical failure and metastasis had developed in 17 and 6 of these 44 patients compared with 9 and none of the 65 patients in the control group (p <0.001). CONCLUSION. Almost 4{\%} of patients with prostate cancer, particularly those with intermediate- and high-risk disease, have gross locally advanced disease at endorectal MRI and have a significantly worse prognosis than matched controls. These patients may be candidates for more aggressive treatment.",
keywords = "MR spectroscopy, MRI, Prostate cancer",
author = "Muglia, {Valdair F.} and Westphalen, {Antonio C.} and Wang, {Zhen J.} and John Kurhanewicz and Carroll, {Peter R.} and Fergus Coakley",
year = "2011",
month = "12",
doi = "10.2214/AJR.11.6425",
language = "English (US)",
volume = "197",
pages = "1369--1374",
journal = "AJR. American journal of roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "6",

}

TY - JOUR

T1 - Endorectal MRI of prostate cancer

T2 - Incremental prognostic importance of gross locally advanced disease

AU - Muglia, Valdair F.

AU - Westphalen, Antonio C.

AU - Wang, Zhen J.

AU - Kurhanewicz, John

AU - Carroll, Peter R.

AU - Coakley, Fergus

PY - 2011/12

Y1 - 2011/12

N2 - OBJECTIVE. The purpose of this study was to determine the frequency and incremental prognostic importance of gross locally advanced disease seen at endorectal MRI in patients with prostate cancer. MATERIALS AND METHODS. We retrospectively identified the cases of all patients with biopsy-proven prostate cancer who underwent pretreatment endorectal MRI over a 6-year period (n = 1777). Three experienced radiologists identified by consensus patients with gross locally advanced disease, defined as unequivocal extracapsular extension or unequivocal seminal vesicle invasion. Outcome among these patients was compared with that in a control group without gross locally advanced disease matched by D'Amico risk stratification. RESULTS. Sixty-six of 1777 (3.7%) patients had gross locally advanced disease. One of 1085 (0.1%) patients had low-risk disease, 25 of 489 (5.1%) had intermediate-risk disease, and 40 of 203 (19.7%) had high-risk disease. Follow-up data were available for 44 of these 66 patients. During a median follow-up period of 79 months, biochemical failure and metastasis had developed in 17 and 6 of these 44 patients compared with 9 and none of the 65 patients in the control group (p <0.001). CONCLUSION. Almost 4% of patients with prostate cancer, particularly those with intermediate- and high-risk disease, have gross locally advanced disease at endorectal MRI and have a significantly worse prognosis than matched controls. These patients may be candidates for more aggressive treatment.

AB - OBJECTIVE. The purpose of this study was to determine the frequency and incremental prognostic importance of gross locally advanced disease seen at endorectal MRI in patients with prostate cancer. MATERIALS AND METHODS. We retrospectively identified the cases of all patients with biopsy-proven prostate cancer who underwent pretreatment endorectal MRI over a 6-year period (n = 1777). Three experienced radiologists identified by consensus patients with gross locally advanced disease, defined as unequivocal extracapsular extension or unequivocal seminal vesicle invasion. Outcome among these patients was compared with that in a control group without gross locally advanced disease matched by D'Amico risk stratification. RESULTS. Sixty-six of 1777 (3.7%) patients had gross locally advanced disease. One of 1085 (0.1%) patients had low-risk disease, 25 of 489 (5.1%) had intermediate-risk disease, and 40 of 203 (19.7%) had high-risk disease. Follow-up data were available for 44 of these 66 patients. During a median follow-up period of 79 months, biochemical failure and metastasis had developed in 17 and 6 of these 44 patients compared with 9 and none of the 65 patients in the control group (p <0.001). CONCLUSION. Almost 4% of patients with prostate cancer, particularly those with intermediate- and high-risk disease, have gross locally advanced disease at endorectal MRI and have a significantly worse prognosis than matched controls. These patients may be candidates for more aggressive treatment.

KW - MR spectroscopy

KW - MRI

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=82455181485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82455181485&partnerID=8YFLogxK

U2 - 10.2214/AJR.11.6425

DO - 10.2214/AJR.11.6425

M3 - Article

C2 - 22109291

AN - SCOPUS:82455181485

VL - 197

SP - 1369

EP - 1374

JO - AJR. American journal of roentgenology

JF - AJR. American journal of roentgenology

SN - 0361-803X

IS - 6

ER -